Stay updated with breaking news from Austind Kim. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Acadia Pharmaceuticals Inc. today announced two new appointments to its executive team. Jennifer J. Rhodes is joining the company as Executive Vice President, Chief Legal Officer and Secretary, and...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) EVP Austin D. Kim sold 590 shares of the firm’s stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $29.96, for a total transaction of $17,676.40. Following the transaction, the executive vice president now owns 46,901 shares of the […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) EVP Austin D. Kim sold 590 shares of the firm’s stock in a transaction on Monday, January 8th. The shares were sold at an average price of $29.96, for a total value of $17,676.40. Following the transaction, the executive vice president now owns 46,901 shares in the […]
ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) had its target price hoisted by equities research analysts at Mizuho from $35.00 to $40.00 in a note issued to investors on Friday, MarketBeat.com reports. The firm presently has a “buy” rating on the biopharmaceutical company’s stock. Mizuho’s target price indicates a potential upside of 27.75% from the […]
StockNews.com lowered shares of ACADIA Pharmaceuticals (NASDAQ:ACAD – Free Report) from a buy rating to a hold rating in a report published on Saturday. Other analysts also recently issued reports about the stock. Cantor Fitzgerald reiterated an overweight rating and issued a $42.00 price target on shares of ACADIA Pharmaceuticals in a report on Thursday, […]